Clinical trials
Phase 2 Neoplasm Metastasis trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
| Completed | 6 |
| Active, not recruiting | 5 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Novartis Pharmaceuticals | 3 |
| Daiichi Sankyo | 2 |
| Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2 |
| AbbVie | 1 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
| I-Mab Biopharma US Limited | 1 |
| Incyte Corporation | 1 |
| Mirati Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 21 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Recurrence | 3 |
| Gastrointestinal Stromal Tumors | 2 |
| Lung Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Acrocephalosyndactylia | 1 |
| Adenocarcinoma of Lung | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.